TSW
PCRX icon

Three Seasons Wealth’s Pacira BioSciences PCRX Stock Holding History

Three Seasons Wealth’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$991K Buy
43,835
+20,504
+88% +$456K 0.38% 67
2025
Q4 		$604K Buy
+23,331
New +$555K 0.06% 91

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Three Seasons Wealth's PCRX Position: Q1 2026 in Review

Three Seasons Wealth increased its Pacira BioSciences (PCRX) stake by 88% in Q1 2026, buying an estimated $456K and bringing the position to 43,835 shares worth $991K. The position accounts for 0.38% of the portfolio, ranked #67.

Three Seasons Wealth first reported a position in PCRX in Q4 2025 and has held it in 2 quarters since. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Three Seasons Wealth held 43,835 shares of Pacira BioSciences worth $991K as of Q1 2026.
  • Three Seasons Wealth bought 20,504 Pacira BioSciences shares in Q1 2026, an estimated $456K.
  • Pacira BioSciences made up 0.38% of Three Seasons Wealth's portfolio in Q1 2026, its #67 holding.
  • Three Seasons Wealth first reported a position in Pacira BioSciences in Q4 2025 and has held it in 2 quarters since.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Three Seasons Wealth's 13F filing for Q1 2026, filed 5 May 2026.